A Review of Animal Models Investigating the Reproductive Effects of Gender-Affirming Hormone Therapy

Nicholas S. Raja,Elizabeth S. Rubin,Molly B. Moravek

DOI: https://doi.org/10.3390/jcm13041183

IF: 3.9

2024-02-20

Journal of Clinical Medicine

Abstract:Gender-affirming hormone therapy (GAHT) is an important component in the process of transitioning for many transgender and gender-diverse (TGD) individuals. Multiple medical organizations recommend fertility preservation counseling prior to initiation of GAHT; however, there remains little high-quality data regarding the impact of GAHT on fertility and reproductive function. A PubMed literature review was performed using Boolean search operators linking keywords or phrases such as "mouse", "rat", "primate", "animal model", "transgender", "gender", "estrogen", "testosterone", "fertility", and "fertility preservation". Recent research has produced a number of animal models of GAHT that utilize similar hormonal regimens and produce similar phenotypic results to those used and observed in human patients. Specific to testosterone(T)-containing GAHT, animals demonstrate loss of menstrual cyclicity with therapy, resumption of menses on cessation of therapy, suppression of gonadotropin levels, and physical changes such as clitoromegaly. Models mimicking GAHT for transmasculine individuals in the peripubertal period demonstrate that pretreatment with GnRHa therapy does not modify the effects of subsequent T administration, which were similar to those described in adult models. Both models suggest promising potential for future fertility with cessation of T. With estradiol (E)-containing GAHT, animals exhibit decreased size of testicles, epididymis, and seminal vesicles, as well as ongoing production of spermatocytes, and seminiferous tubule vacuolization. Given the ethical challenges of conducting human studies in this area, high-fidelity animal models represent a promising opportunity for investigation and could eventually transform clinical counseling about the necessity of fertility preservation. Future studies should better delineate the interactions (if any exist) between treatment attributes such as dosing and duration with the extent of reversibility of reproductive perturbations. The development of models of peripubertal feminizing GAHT is an additional area for future work.

medicine, general & internal

What problem does this paper attempt to address?

The paper attempts to address the issue of the impact of Gender-Affirming Hormone Therapy (GAHT) on reproductive function, particularly in transgender and gender-diverse individuals. Specifically, the paper investigates the specific effects of GAHT on reproductive capacity through animal models and explores whether these effects are reversible. Additionally, the paper focuses on changes in reproductive function in individuals who begin GAHT before puberty.

The authors evaluated the effects of different hormone therapy regimens (such as testosterone and estradiol) on the structure of reproductive organs, levels of reproductive hormones, and reproductive function through a literature review and animal experiments. The study found that GAHT using testosterone leads to the loss of menstrual cycles, but this can be restored after stopping the treatment; whereas GAHT using estradiol results in a reduction in the size of the testes, epididymis, and seminal vesicles, but spermatogenesis continues. These findings are significant for understanding the long-term impact of GAHT on reproductive capacity and provide data support for the development of future clinical guidelines.